Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin

Abstract

Mutations in the Bdnf gene, which produces transcripts with either short or long 3′ untranslated regions (3′ UTRs), cause human obesity; however, the precise role of brain-derived neurotrophic factor (BDNF) in the regulation of energy balance is unknown. Here we show the relationship between Bdnf mRNA with a long 3′ UTR (long 3′ UTR Bdnf mRNA), leptin, neuronal activation and body weight. We found that long 3′ UTR Bdnf mRNA was enriched in the dendrites of hypothalamic neurons and that insulin and leptin could stimulate its translation in dendrites. Furthermore, mice harboring a truncated long Bdnf 3′ UTR developed severe hyperphagic obesity, which was completely reversed by viral expression of long 3′ UTR Bdnf mRNA in the hypothalamus. In these mice, the ability of leptin to activate hypothalamic neurons and inhibit food intake was compromised despite normal activation of leptin receptors. These results reveal a novel mechanism linking leptin action to BDNF expression during hypothalamic-mediated regulation of body weight, while also implicating dendritic protein synthesis in this process.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Mice lacking long 3′ UTR Bdnf mRNA show severe hyperphagic obesity.
Figure 2: Viral expression of long 3′ UTR Bdnf mRNA in the VMH corrects the obesity syndrome in Bdnfklox/klox mice.
Figure 3: Insulin stimulates local translation of transcripts containing the long Bdnf 3′ UTR in the dendrites of hypothalamic neurons.
Figure 4: Leptin activates hypothalamic BDNF-expressing neurons through network activity.
Figure 5: Leptin normally activates LepRb in Bdnfklox/klox mice.
Figure 6: Leptin-induced neuronal activation is impaired in Bdnfklox/klox mice.

References

  1. 1

    Kopelman, P.G. Obesity as a medical problem. Nature 404, 635–643 (2000).

  2. 2

    Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432 (1994).

  3. 3

    Woods, S.C., Lotter, E.C., McKay, L.D. & Porte, D. Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282, 503–505 (1979).

  4. 4

    Nakazato, M. et al. A role for ghrelin in the central regulation of feeding. Nature 409, 194–198 (2001).

  5. 5

    Kojima, M. et al. Ghrelin is a growth-hormone–releasing acylated peptide from stomach. Nature 402, 656–660 (1999).

  6. 6

    Shintani, M. et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50, 227–232 (2001).

  7. 7

    Horvath, T.L., Diano, S., Sotonyi, P., Heiman, M. & Tschop, M. Minireview: ghrelin and the regulation of energy balance—a hypothalamic perspective. Endocrinology 142, 4163–4169 (2001).

  8. 8

    Tang-Christensen, M. et al. Central administration of GLP-1-(7–36) amide inhibits food and water intake in rats. Am. J. Physiol. 271, R848–R856 (1996).

  9. 9

    Turton, M.D. et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69–72 (1996).

  10. 10

    Batterham, R.L. et al. Gut hormone PYY(3–36) physiologically inhibits food intake. Nature 418, 650–654 (2002).

  11. 11

    Pocai, A. et al. Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J. Clin. Invest. 116, 1081–1091 (2006).

  12. 12

    He, W., Lam, T.K., Obici, S. & Rossetti, L. Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat. Neurosci. 9, 227–233 (2006).

  13. 13

    Loftus, T.M. et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379–2381 (2000).

  14. 14

    Cota, D. et al. Hypothalamic mTOR signaling regulates food intake. Science 312, 927–930 (2006).

  15. 15

    Flier, J.S. Obesity wars: molecular progress confronts an expanding epidemic. Cell 116, 337–350 (2004).

  16. 16

    Morton, G.J., Cummings, D.E., Baskin, D.G., Barsh, G.S. & Schwartz, M.W. Central nervous system control of food intake and body weight. Nature 443, 289–295 (2006).

  17. 17

    Wynne, K., Stanley, S., McGowan, B. & Bloom, S. Appetite control. J. Endocrinol. 184, 291–318 (2005).

  18. 18

    Huang, E.J. & Reichardt, L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677–736 (2001).

  19. 19

    Lyons, W.E. et al. Brain-derived neurotrophic factor–deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl. Acad. Sci. USA 96, 15239–15244 (1999).

  20. 20

    Kernie, S.G., Liebl, D.J. & Parada, L.F. BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 19, 1290–1300 (2000).

  21. 21

    Xu, B. et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci. 6, 736–742 (2003).

  22. 22

    Rios, M. et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol. Endocrinol. 15, 1748–1757 (2001).

  23. 23

    Lin, C.R. et al. Molecular cloning of a brain-specific calcium/calmodulin-dependent protein kinase. Proc. Natl. Acad. Sci. USA 84, 5962–5966 (1987).

  24. 24

    Han, J.C. et al. Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N. Engl. J. Med. 359, 918–927 (2008).

  25. 25

    Yeo, G.S. et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat. Neurosci. 7, 1187–1189 (2004).

  26. 26

    Gray, J. et al. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 55, 3366–3371 (2006).

  27. 27

    Thorleifsson, G. et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 41, 18–24 (2009).

  28. 28

    Hotta, K. et al. Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population. J. Hum. Genet. 54, 727–731 (2009).

  29. 29

    Unger, T.J., Calderon, G.A., Bradley, L.C., Sena-Esteves, M. & Rios, M. Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J. Neurosci. 27, 14265–14274 (2007).

  30. 30

    Cao, L. et al. Molecular therapy of obesity and diabetes by a physiological autoregulatory approach. Nat. Med. 15, 447–454 (2009).

  31. 31

    Timmusk, T. et al. Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10, 475–489 (1993).

  32. 32

    An, J.J. et al. Distinct role of long 3′ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 134, 175–187 (2008).

  33. 33

    Steward, O. & Schuman, E.M. Compartmentalized synthesis and degradation of proteins in neurons. Neuron 40, 347–359 (2003).

  34. 34

    Bramham, C.R. & Wells, D.G. Dendritic mRNA: transport, translation and function. Nat. Rev. Neurosci. 8, 776–789 (2007).

  35. 35

    Miller, S. et al. Disruption of dendritic translation of CaMKIIα impairs stabilization of synaptic plasticity and memory consolidation. Neuron 36, 507–519 (2002).

  36. 36

    Kang, H. & Schuman, E.M. A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity. Science 273, 1402–1406 (1996).

  37. 37

    Huber, K.M., Kayser, M.S. & Bear, M.F. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288, 1254–1257 (2000).

  38. 38

    Martin, K.C. et al. Synapse-specific, long-term facilitation of aplysia sensory to motor synapses: a function for local protein synthesis in memory storage. Cell 91, 927–938 (1997).

  39. 39

    Coppola, V. & Tessarollo, L. Control of hyperphagia prevents obesity in BDNF heterozygous mice. Neuroreport 15, 2665–2668 (2004).

  40. 40

    Aakalu, G., Smith, W.B., Nguyen, N., Jiang, C. & Schuman, E.M. Dynamic visualization of local protein synthesis in hippocampal neurons. Neuron 30, 489–502 (2001).

  41. 41

    Schwartz, M.W. & Porte, D. Jr. Diabetes, obesity, and the brain. Science 307, 375–379 (2005).

  42. 42

    Chua, S.C. Jr. et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 271, 994–996 (1996).

  43. 43

    Lee, G.H. et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632–635 (1996).

  44. 44

    Münzberg, H., Huo, L., Nillni, E.A., Hollenberg, A.N. & Bjorbaek, C. Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology 144, 2121–2131 (2003).

  45. 45

    DeFalco, J. et al. Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science 291, 2608–2613 (2001).

  46. 46

    Gorski, J.A., Zeiler, S.R., Tamowski, S. & Jones, K.R. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J. Neurosci. 23, 6856–6865 (2003).

  47. 47

    Scott, M.M. et al. Leptin targets in the mouse brain. J. Comp. Neurol. 514, 518–532 (2009).

  48. 48

    Hübschle, T. et al. Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. J. Neurosci. 21, 2413–2424 (2001).

  49. 49

    Myers, M.G., Cowley, M.A. & Munzberg, H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 70, 537–556 (2008).

  50. 50

    Joseph-Bravo, P., Perez-Martinez, L., Lezama, L., Morales-Chapa, C. & Charli, J.L. An improved method for the expression of TRH in serum-supplemented primary cultures of fetal hypothalamic cells. Brain Res. Brain Res. Protoc. 9, 93–104 (2002).

  51. 51

    Gharami, K., Xie, Y., An, J.J., Tonegawa, S. & Xu, B. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice. J. Neurochem. 105, 369–379 (2008).

Download references

Acknowledgements

This work was supported by the grants from the US National Institutes of Health to B.X. (R01 DK089237, R21 DK081008 and R01 NS050596), E.G.W. (F30 DK084717) and F.V. (F31 NS060453) and from the American Diabetes Association to B.X. (7-07-RA-183).

Author information

G.-Y.L. performed experiments addressing the obesity syndrome, local protein synthesis, viral BDNF expression, coexpression of BDNF and TrkB with the leptin receptor, STAT3 activation and c-Fos induction. J.J.A. analyzed Bdnf mRNA subcellular localization and gene expression. K.G. characterized the obesity phenotype of the Bdnfklox/klox mice. E.G.W. created viral constructs and helped G.-Y.L. with stereotaxic AAV microinjection. F.V. generated the reporter constructs for local BDNF synthesis. K.R.J. provided the Bdnfklox/klox mouse strain. B.X. supervised the project. B.X. and G.-Y.L. wrote the manuscript.

Correspondence to Baoji Xu.

Ethics declarations

Competing interests

B.X., J.J.A. and E.G.W. are co-inventors on a patent application filed by Georgetown University that is related to the technology described in this paper.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–8 and Supplementary Methods (PDF 6135 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Liao, G., An, J., Gharami, K. et al. Dendritically targeted Bdnf mRNA is essential for energy balance and response to leptin. Nat Med 18, 564–571 (2012). https://doi.org/10.1038/nm.2687

Download citation

Further reading